Avoid common mistakes on your manuscript.
1 Correction to: Targeted Oncology (2020) 15:115–126 https://doi.org/10.1007/s11523-020-00698-x
Faloppi L, Puzzoni M, Casadei Gardini A, Silvestris N, Masi G, Marisi G, et al. Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study. Targeted Oncology. 2020;15:115-126
Page 115 and 126: The listing of the author names and affiliations, which previously read:
“Luca Faloppi1,2, Marco Puzzoni2, Andrea Casadei Gardini3, Nicola Silvestris4, Gianluca Masi5, Giorgia Marisi3, Caterina Vivaldi5, Cosmo Damiano Gadaleta4, Pina Ziranu2, Maristella Bianconi6, Cristian Loretelli7, Laura Demurtas2, Eleonora Lai2, Riccardo Giampieri8, Eva Galizia1, Paola Ulivi3, Nicola Battelli1, Alfredo Falcone5, Stefano Cascinu9, Mario Scartozzi2,10
1 Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy
2 Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy
3 Medical Oncology Unit, IRCSS-IRST, Meldola, Italy
4 Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy
5 Medical Oncology Unit, University of Pisa, Pisa, Italy
6 Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy
7 International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi “L. Sacco” Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
8 Oncology Department, Polytechnic University of Marche, Ancona, Italy
9 Medical Oncology Unit, University of Modena, Modena, Italy
10 Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario “Duilio Casula”, S.S. 554, Km 4,500 Bivio per Sestu, Monserrato, CA 09042, Italy”
should read:
“Luca Faloppi1,2, Marco Puzzoni2, Andrea Casadei Gardini3, Nicola Silvestris4, Gianluca Masi5, Giorgia Marisi3, Caterina Vivaldi5, Cosmo Damiano Gadaleta4, Pina Ziranu2, Maristella Bianconi6, Cristian Loretelli7, Laura Demurtas2, Eleonora Lai2, Riccardo Giampieri8, Eva Galizia1, Paola Ulivi9, Nicola Battelli1, Alfredo Falcone5, Stefano Cascinu10, Mario Scartozzi2,11
1 Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy
2 Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy
3 Medical Oncology Unit, IRCSS-IRST, Meldola, Italy
4 Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy
5 Medical Oncology Unit, University of Pisa, Pisa, Italy
6 Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy
7 International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi “L. Sacco” Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
8 Oncology Department, Polytechnic University of Marche, Ancona, Italy
9 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy
10 Medical Oncology Unit, University of Modena, Modena, Italy
11 Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario “Duilio Casula”, S.S. 554, Km 4,500 Bivio per Sestu, Monserrato, CA 09042, Italy
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Faloppi, L., Puzzoni, M., Gardini, A.C. et al. Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study. Targ Oncol 15, 801–802 (2020). https://doi.org/10.1007/s11523-020-00773-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11523-020-00773-3